vs
Side-by-side financial comparison of Pacira BioSciences, Inc. (PCRX) and Riot Platforms, Inc. (RIOT). Click either name above to swap in a different company.
Pacira BioSciences, Inc. is the larger business by last-quarter revenue ($196.9M vs $152.8M, roughly 1.3× Riot Platforms, Inc.). On growth, Riot Platforms, Inc. posted the faster year-over-year revenue change (7.2% vs 5.1%). Pacira BioSciences, Inc. produced more free cash flow last quarter ($43.5M vs $-774.3M). Over the past eight quarters, Riot Platforms, Inc.'s revenue compounded faster (38.8% CAGR vs 8.5%).
Pacira BioSciences, Inc. is a specialty pharmaceutical company focused on developing and commercializing non-opioid pain management solutions. Its core product line targets post-surgical pain relief for patients, serving hospitals, ambulatory surgery centers and other healthcare providers primarily in the U.S., with ongoing expansion efforts in select international markets.
Riot Platforms, Inc. is a leading U.S.-based enterprise focused on Bitcoin mining, operating multiple large-scale, energy-efficient data centers across North America. It also invests in blockchain infrastructure development and holds Bitcoin as a core long-term reserve asset, centering its business strategy around the digital asset ecosystem.
PCRX vs RIOT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.9M | $152.8M |
| Net Profit | — | $-690.7M |
| Gross Margin | 79.5% | — |
| Operating Margin | 1.2% | -447.9% |
| Net Margin | — | -452.0% |
| Revenue YoY | 5.1% | 7.2% |
| Net Profit YoY | — | -606.3% |
| EPS (diluted) | $0.05 | $-1.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.9M | $152.8M | ||
| Q3 25 | $179.5M | $180.2M | ||
| Q2 25 | $181.1M | $153.0M | ||
| Q1 25 | $168.9M | $161.4M | ||
| Q4 24 | $187.3M | $142.6M | ||
| Q3 24 | $168.6M | $84.8M | ||
| Q2 24 | $178.0M | $70.0M | ||
| Q1 24 | $167.1M | $79.3M |
| Q4 25 | — | $-690.7M | ||
| Q3 25 | $5.4M | $104.5M | ||
| Q2 25 | $-4.8M | $219.5M | ||
| Q1 25 | $4.8M | $-296.4M | ||
| Q4 24 | — | $136.4M | ||
| Q3 24 | $-143.5M | $-154.4M | ||
| Q2 24 | $18.9M | $-84.4M | ||
| Q1 24 | $9.0M | $211.8M |
| Q4 25 | 79.5% | — | ||
| Q3 25 | 80.9% | — | ||
| Q2 25 | 77.4% | — | ||
| Q1 25 | 79.7% | — | ||
| Q4 24 | 78.7% | — | ||
| Q3 24 | 76.9% | — | ||
| Q2 24 | 75.1% | — | ||
| Q1 24 | 71.6% | — |
| Q4 25 | 1.2% | -447.9% | ||
| Q3 25 | 3.5% | 44.4% | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 1.2% | -144.9% | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | -82.8% | -143.3% | ||
| Q2 24 | 15.9% | -167.2% | ||
| Q1 24 | 7.9% | — |
| Q4 25 | — | -452.0% | ||
| Q3 25 | 3.0% | 58.0% | ||
| Q2 25 | -2.7% | 143.4% | ||
| Q1 25 | 2.8% | -183.6% | ||
| Q4 24 | — | 95.7% | ||
| Q3 24 | -85.1% | -182.1% | ||
| Q2 24 | 10.6% | -120.6% | ||
| Q1 24 | 5.4% | 267.1% |
| Q4 25 | $0.05 | $-1.89 | ||
| Q3 25 | $0.12 | $0.26 | ||
| Q2 25 | $-0.11 | $0.58 | ||
| Q1 25 | $0.10 | $-0.90 | ||
| Q4 24 | $0.38 | $0.39 | ||
| Q3 24 | $-3.11 | $-0.54 | ||
| Q2 24 | $0.39 | $-0.32 | ||
| Q1 24 | $0.19 | $0.51 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $238.4M | $233.5M |
| Total DebtLower is stronger | $372.2M | $840.8M |
| Stockholders' EquityBook value | $693.1M | $2.9B |
| Total Assets | $1.3B | $3.9B |
| Debt / EquityLower = less leverage | 0.54× | 0.29× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $238.4M | $233.5M | ||
| Q3 25 | $246.3M | $330.7M | ||
| Q2 25 | $445.9M | $255.4M | ||
| Q1 25 | $493.6M | $163.7M | ||
| Q4 24 | $484.6M | $277.9M | ||
| Q3 24 | $453.8M | $355.7M | ||
| Q2 24 | $404.2M | $481.2M | ||
| Q1 24 | $325.9M | $688.5M |
| Q4 25 | $372.2M | $840.8M | ||
| Q3 25 | $376.7M | $5.3M | ||
| Q2 25 | $580.5M | $5.3M | ||
| Q1 25 | $583.4M | $5.3M | ||
| Q4 24 | $585.3M | $584.6M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $693.1M | $2.9B | ||
| Q3 25 | $727.2M | $3.5B | ||
| Q2 25 | $757.8M | $3.3B | ||
| Q1 25 | $798.5M | $2.9B | ||
| Q4 24 | $778.3M | $3.1B | ||
| Q3 24 | $749.6M | $2.7B | ||
| Q2 24 | $879.3M | $2.6B | ||
| Q1 24 | $892.2M | $2.5B |
| Q4 25 | $1.3B | $3.9B | ||
| Q3 25 | $1.3B | $4.5B | ||
| Q2 25 | $1.5B | $4.3B | ||
| Q1 25 | $1.6B | $3.7B | ||
| Q4 24 | $1.6B | $3.9B | ||
| Q3 24 | $1.5B | $2.9B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.6B | $2.6B |
| Q4 25 | 0.54× | 0.29× | ||
| Q3 25 | 0.52× | 0.00× | ||
| Q2 25 | 0.77× | 0.00× | ||
| Q1 25 | 0.73× | 0.00× | ||
| Q4 24 | 0.75× | 0.19× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $43.7M | $-572.9M |
| Free Cash FlowOCF − Capex | $43.5M | $-774.3M |
| FCF MarginFCF / Revenue | 22.1% | -506.6% |
| Capex IntensityCapex / Revenue | 0.1% | 131.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $136.7M | $-1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $43.7M | $-572.9M | ||
| Q3 25 | $60.8M | $-114.0M | ||
| Q2 25 | $12.0M | $-231.3M | ||
| Q1 25 | $35.5M | $-122.1M | ||
| Q4 24 | $33.1M | $-255.1M | ||
| Q3 24 | $53.9M | $-56.3M | ||
| Q2 24 | $53.2M | $-42.5M | ||
| Q1 24 | $49.1M | $-57.9M |
| Q4 25 | $43.5M | $-774.3M | ||
| Q3 25 | $57.0M | $-139.7M | ||
| Q2 25 | $9.3M | $-291.7M | ||
| Q1 25 | $26.9M | $-154.9M | ||
| Q4 24 | $31.0M | $-495.4M | ||
| Q3 24 | $49.8M | $-127.6M | ||
| Q2 24 | $51.6M | $-96.1M | ||
| Q1 24 | $46.3M | $-115.2M |
| Q4 25 | 22.1% | -506.6% | ||
| Q3 25 | 31.7% | -77.5% | ||
| Q2 25 | 5.1% | -190.7% | ||
| Q1 25 | 15.9% | -96.0% | ||
| Q4 24 | 16.6% | -347.5% | ||
| Q3 24 | 29.6% | -150.5% | ||
| Q2 24 | 29.0% | -137.2% | ||
| Q1 24 | 27.7% | -145.2% |
| Q4 25 | 0.1% | 131.8% | ||
| Q3 25 | 2.2% | 14.3% | ||
| Q2 25 | 1.5% | 39.5% | ||
| Q1 25 | 5.1% | 20.4% | ||
| Q4 24 | 1.1% | 168.6% | ||
| Q3 24 | 2.4% | 84.1% | ||
| Q2 24 | 0.9% | 76.5% | ||
| Q1 24 | 1.7% | 72.3% |
| Q4 25 | — | — | ||
| Q3 25 | 11.20× | -1.09× | ||
| Q2 25 | — | -1.05× | ||
| Q1 25 | 7.37× | — | ||
| Q4 24 | — | -1.87× | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.82× | — | ||
| Q1 24 | 5.47× | -0.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PCRX
| EXPAREL | $155.8M | 79% |
| ZILRETTA | $33.0M | 17% |
| Iovera | $7.0M | 4% |
RIOT
| Bitcoin Mining Segment | $131.7M | 86% |
| Engineering Segment | $21.1M | 14% |
